Roche Holding AG (LTS:0QOK)
CHF 267.45 -2.6 (-0.96%) Market Cap: 216.57 Bil Enterprise Value: 242.19 Bil PE Ratio: 20.33 PB Ratio: 7.41 GF Score: 85/100

Q3 2022 Roche Holding AG Corporate Sales Presentation Transcript

Oct 18, 2022 / 12:00PM GMT
Release Date Price: CHF324.8 (-1.68%)

Oct 18, 2022 / 12:00PM GMT
Presentation
Oct 18, 2022 / 12:00PM GMT

=====================
Corporate Participants
=====================
* Alan Hippe
Roche Holding AG - Chief Financial & Information Officer
* Bruno Eschli
Roche Holding AG - Head of IR
* Severin Schwan
Roche Holding AG - CEO & Executive Director
* Thomas Schinecker
Roche Holding AG - CEO of Roche Diagnostics
* William N. Anderson
Roche Holding AG - CEO of Roche Pharmaceuticals

=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
* Emily Field
Barclays Bank PLC, Research Division - Research Analyst
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - Research Analyst
* Eric Le Berrigaud
Stifel, Nicolaus & Company, Incorporated, Research Division - Research Analyst
* Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst
*

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot